Skip to Main Content

A trade group for pharmaceutical wholesalers filed a lawsuit claiming a New York state law that requires opioid makers and distributors to fund a first-in-the-nation program for covering costs for treatment, prevention, and recovery is unconstitutional.

The Healthcare Distribution Alliance claims the Opioid Stewardship Act, which went into effect on July 1, will force opioid makers and wholesalers to pay an estimated $600 million in surcharges over the next six years and, therefore, unfairly singles out these companies to “bear liability for a complex public health epidemic.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED